← Leaderboards
Kamehameha K Wong
City Of Hope National Medical Center
$694,246
Attributed
$694,246
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$6,457,243 · 3
By mechanism
P01$6,457,243 · 3
Top collaborators
No co-investigators on record.
Most similar at City Of Hope National Medical Center
Same institution · by research overlap
- John Joseph Rossi$25,916,442
- Michael C Jensen$5,983,472
- Andrew A. Raubitschek$10,642,515
- Saswati Chatterjee$4,059,760
- Jiing-Kuan Lee$237,837
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyAdeno Associated Virus GroupRecombinant VirusTransfection /Expression VectorClinical ResearchHuman SubjectPolymerase Chain ReactionCardiovascular DisorderNeoplasm /Cancer TherapyNonhodgkin'S LymphomaNonhuman Therapy EvaluationGenetic TransductionStem Cell TransplantationCd34 MoleculeClinical TrialsAids Related Neoplasm /CancerScid MouseHuman Therapy EvaluationAntisense Nucleic AcidVirus IntegrationExpression CloningLaboratory RabbitMolecular Biology Information SystemTissue /Cell Culture
Grant awards (9)
GENE THERAPY APPROACHES FOR BLOOD AND VASCULAR DISEASES$1,496,835
P01 · FY2004 · HL
GENE THERAPY APPROACHES FOR BLOOD AND VASCULAR DISEASES$1,458,709
P01 · FY2003 · HL
GENE THERAPY APPROACHES FOR BLOOD AND VASCULAR DISEASES$1,421,694
P01 · FY2002 · HL
ANALYSIS AND PROMOTION OF RAAV VECTOR INTEGRATION$347,123
P01 · FY2002 · HL
RECOMBINANT ADENOASSOCIATED VIRUS MEDIATED GENE THERAPY$0
P01 · FY2002 · CA
RECOMBINANT ADENOASSOCIATED VIRUS MEDIATED GENE THERAPY$0
P01 · FY2001 · CA
GENE THERAPY APPROACHES FOR BLOOD AND VASCULAR DISEASES$1,385,759
P01 · FY2000 · HL
ANALYSIS AND PROMOTION OF RAAV VECTOR INTEGRATION$347,123
P01 · FY2000 · HL
RECOMBINANT ADENOASSOCIATED VIRUS MEDIATED GENE THERAPY$0
P01 · FY2000 · CA